Related Experiment Video
Updated: Jul 21, 2026
Establishment of a Segmental Femoral Critical-size Defect Model in Mice Stabilized by Plate Osteosynthesis
Published on: October 12, 2016
Biglycan-deficient mice have delayed osteogenesis after marrow ablation
X-D Chen1, M R Allen, S Bloomfield
1Craniofacial & Skeletal Disease Branch, NIDCR, Bethesda, MD, USA.
Biglycan deficiency impairs bone formation after marrow ablation. Wild-type mice showed greater bone regeneration compared to biglycan-deficient mice, indicating biglycan
Area of Science:
- Skeletal biology
- Bone metabolism
- Proteoglycan function
Background:
- Biglycan (bgn) is a skeletal proteoglycan regulating collagen and TGF-beta.
- Biglycan-deficient mice exhibit osteopenia and bone marrow stromal cell defects.
Purpose of the Study:
- To investigate if bone formation is compromised in biglycan deficiency following physiological stress.
- To test the hypothesis that bgn absence impedes osteogenesis.
Main Methods:
- In vivo bone marrow ablation assay in wild-type (wt) and bgn-deficient (bgn-KO) mice.
- Analysis of femora at 7, 10, and 17 days post-surgery using X-ray and peripheral quantitative computed tomography (pQCT).
Main Results:
- Bone marrow ablation induced new bone formation in both genotypes.
- Wild-type mice exhibited greater bone formation than bgn-KO mice at day 10 post-ablation.
- The effect was temporal and localized to mid-shaft cancellous bone.
Conclusions:
- Absence of biglycan directly impedes bone formation following marrow ablation.
- Biglycan plays a crucial role in controlling osteogenesis after skeletal injury.
More Related Videos
11:06Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
05:10Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
Published on: February 7, 2025